| 摘要 |
<p>Polymorphic forms of the tyrosine kinase inhibitor OSI-906, preparation, pharmaceutical compositions, and uses thereof. The invention includes methods of treating diseases such as cancer, including cancer mediated at least in part by IGF-1 R and/or IR, with the polymorphs and compositions. This Abstract is not limiting of the invention.</p> |
| 申请人 |
OSI PHARMACEUTICALS, LLC;CASTELHANO, ARLINDO, L.;ENGERS, DAVID, A.;HANKO, JASON, A.;RECHKA, JOSEF, A.;TENG, JING;YANG, YONGLAI |
发明人 |
CASTELHANO, ARLINDO, L.;ENGERS, DAVID, A.;HANKO, JASON, A.;RECHKA, JOSEF, A.;TENG, JING;YANG, YONGLAI |
